Literature DB >> 21041626

Direct roles of the signaling kinase RSK2 in Cdc25C activation during Xenopus oocyte maturation.

Ruoning Wang1, Sung Yun Jung, Chuan Fen Wu, Jun Qin, Ryuji Kobayashi, Gary E Gallick, Jian Kuang.   

Abstract

The induction of M phase in eukaryotic cell cycles requires robust activation of Cdc2/cyclin B by Cdc25, which itself is robustly activated by serine/threonine phosphorylations. Although multiple protein kinases that directly activate Cdc25C have been identified, whether the combination of different primary phosphorylations of Cdc25C is sufficient to fully activate Cdc25C has not been determined. By analyzing the GST-Cdc25C phosphorylating activity in Xenopus egg extracts, we previously defined roles of MAPK and Cdc2/cyclin B in partially activating Cdc25C and predicted the presence of another major Cdc25C-activating kinase. In this study, we demonstrate that this missing kinase is RSK2, which phosphorylates three sites in Cdc25C and also partially activates Cdc25C. However, the phosphorylations catalyzed by MAPK, Cdc2, and RSK2 fail to fully activate Cdc25C, suggesting that additional biochemical events are required to fully activate this key cell cycle regulator.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21041626      PMCID: PMC2993414          DOI: 10.1073/pnas.1003528107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Periodic changes in phosphorylation of the Xenopus cdc25 phosphatase regulate its activity.

Authors:  T Izumi; D H Walker; J L Maller
Journal:  Mol Biol Cell       Date:  1992-08       Impact factor: 4.138

2.  Regulation of the cdc25 protein during the cell cycle in Xenopus extracts.

Authors:  A Kumagai; W G Dunphy
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

3.  Multiple forms of maturation-promoting factor in unfertilized Xenopus eggs.

Authors:  J Kuang; J E Penkala; C L Ashorn; D A Wright; G F Saunders; P N Rao
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

4.  Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes.

Authors:  Y Masui; C L Markert
Journal:  J Exp Zool       Date:  1971-06

5.  Partial purification and characterization of the maturation-promoting factor from eggs of Xenopus laevis.

Authors:  M Wu; J C Gerhart
Journal:  Dev Biol       Date:  1980-10       Impact factor: 3.582

6.  Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1.

Authors:  S A Richards; V C Dreisbach; L O Murphy; J Blenis
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

7.  Dissecting the M phase-specific phosphorylation of serine-proline or threonine-proline motifs.

Authors:  Chuan Fen Wu; Ruoning Wang; Qianjin Liang; Jianjiao Liang; Wenke Li; Sung Yun Jung; Jun Qin; Sue-Hwa Lin; Jian Kuang
Journal:  Mol Biol Cell       Date:  2010-03-10       Impact factor: 4.138

8.  Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.

Authors:  Philippe P Roux; Bryan A Ballif; Rana Anjum; Steven P Gygi; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

9.  Oscillation of MPF is accompanied by periodic association between cdc25 and cdc2-cyclin B.

Authors:  C Jessus; D Beach
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

View more
  7 in total

1.  RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.

Authors:  Guoyu Yu; Yu-Chen Lee; Chien-Jui Cheng; Chuan-Fen Wu; Jian H Song; Gary E Gallick; Li-Yuan Yu-Lee; Jian Kuang; Sue-Hwa Lin
Journal:  Mol Cancer Res       Date:  2014-09-04       Impact factor: 5.852

Review 2.  CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.

Authors:  Paul Dent; Yong Tang; Adly Yacoub; Yun Dai; Paul B Fisher; Steven Grant
Journal:  Mol Interv       Date:  2011-04

3.  RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B.

Authors:  C F Wu; S Liu; Y-C Lee; R Wang; S Sun; F Yin; W G Bornmann; L-Y Yu-Lee; G E Gallick; W Zhang; S-H Lin; J Kuang
Journal:  Oncogene       Date:  2013-05-27       Impact factor: 9.867

4.  A dynamical model of oocyte maturation unveils precisely orchestrated meiotic decisions.

Authors:  Benjamin Pfeuty; Jean-Francois Bodart; Ralf Blossey; Marc Lefranc
Journal:  PLoS Comput Biol       Date:  2012-01-05       Impact factor: 4.475

5.  Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase.

Authors:  Corinna Kosnopfel; Tobias Sinnberg; Birgit Sauer; Heike Niessner; Anja Schmitt; Elena Makino; Andrea Forschner; Stephan Hailfinger; Claus Garbe; Birgit Schittek
Journal:  Oncotarget       Date:  2017-05-30

6.  Phosphorylation of CDC25C by AMP-activated protein kinase mediates a metabolic checkpoint during cell-cycle G2/M-phase transition.

Authors:  Yuqing Shen; John William Sherman; Xuyong Chen; Ruoning Wang
Journal:  J Biol Chem       Date:  2018-02-21       Impact factor: 5.157

7.  Phosphorylation of ARPP19 by protein kinase A prevents meiosis resumption in Xenopus oocytes.

Authors:  Aude Dupré; Enrico M Daldello; Angus C Nairn; Catherine Jessus; Olivier Haccard
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.